Parental traits offer new clues to predicting neurodevelopmental disorders in children

Predicting the trajectory of neurodevelopmental and psychiatric disorders like autism or schizophrenia is difficult because they can be influenced by many different genetic and environmental factors.

Jim Wilson’s next venture, a surprise startup shutdown, & Lilly’s Zepbound strategy

What’s behind the “great abandonment” in gene therapy R&D? How does a startup spend $213 million? And is Adam an optimist? We talk about all

August 29, 2024

Glenmark, Alphamab deal worth up to $700M; Tourmaline’s $150M offering; Repare records $40M milestone

Plus, news about Vera Therapeutics and Cellectar Biosciences: Alphamab Oncology, Glenmark ink licensing deal: Per the agreement, Glenmark will spend up to $700.8 million in

January 26, 2024

Experts warn of ‘silent epidemic’ of high cholesterol in the UK

The most comprehensive research into cholesterol ever conducted in the UK has found 54% of Brits could have high total cholesterol levels.

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.